-
公开(公告)号：KR1020120111105A
公开(公告)日：2012-10-10
申请号：KR1020110029410
申请日：2011-03-31
Applicant: 한국식품연구원
IPC: A23L3/3472 , A23B7/10 , A23L19/20
CPC classification number: A23B7/10 , A23L33/10 , A23Y2220/00
Abstract: PURPOSE: Lactic acid bacteria low-salinity fermented food containing rosemary, and a growth controlling method of harmful microorganisms are provided to control the abnormal fermentation by producing the lactic acid bacteria low-salinity fermented food. CONSTITUTION: Lactic acid bacteria low-salinity fermented food contains 0.01-2 parts of rosemary by weight and 2.0-2.5 parts of salt by weight. The lactic acid bacteria low-salinity fermented food additionally includes more than one ingredient selected from the group consisting of pear, radish, and onion. The lactic acid bacteria low-salinity fermented food has a growth controlling effect to harmful microorganisms including Bacillus cereus, Pseudomonas aeruginosa, or Escherichia coli. The lactic acid bacteria low-salinity fermented food is kimchi. [Reference numerals] (AA) Outer shape; (BB) Total palatability; (CC) Smell; (DD) Texture; (EE) Taste; (FF) 2.5% control group; (GG) 2.5% production example
Abstract translation: 目的：提供含有迷迭香的乳酸菌低盐度发酵食品和有害微生物的生长控制方法，通过生产乳酸菌低盐度发酵食品来控制异常发酵。 构成：乳酸菌低盐度发酵食品含有0.01-2份重量的迷迭香和2.0-2.5份重量的盐。 乳酸菌低盐度发酵食品还包括选自梨，萝卜和洋葱的多种成分。 乳酸菌低盐度发酵食品对包括蜡状芽孢杆菌，铜绿假单胞菌或大肠杆菌在内的有害微生物具有生长控制作用。 乳酸菌低盐度发酵食品是泡菜。 （附图标记）（AA）外形; （BB）总可口性; （CC）气味; （DD）纹理; （EE）品味; （FF）2.5％对照组; （GG）2.5％的生产实例
-
公开(公告)号：KR1020120067821A
公开(公告)日：2012-06-26
申请号：KR1020100129432
申请日：2010-12-16
Applicant: 한국식품연구원
IPC: A61K31/09 , A61K31/343 , A61K36/79 , A61P3/10
Abstract: PURPOSE: A therapeutic agent containing complex lignan for treating type 2 diabetes is provided to suppress blood glucose and to reduce insulin resistance. CONSTITUTION: A therapeutic agent for treating type 2 diabetes contains complex lignin of 3-5 weight parts of schizandrin, 2-4 weight parts of gomisin A, and 0.5-1.5 weight parts of angeloylgomisin H. The schizandrin is schizandrin A, schizandrin B, schizandrin C, or mixture thereof. The complex lignin additionally contains schizandrol, angeloylgomisin O, angeloylgomisin P, epigomisin, pregomoisin, or deoxyschizandrin lignan. A health food for treating type 2 diabetes contains the complex lignan as an active ingredient. A method for reducing blood glucose comprises a step of administering the complex lignan to a subject by oral or intravenous injection, intranasal inhalation, or intramuscular or intraperitoneal administration.
Abstract translation: 目的：提供含有用于治疗2型糖尿病的复合木素素的治疗剂，以抑制血糖和降低胰岛素抵抗。 构成：用于治疗2型糖尿病的治疗剂含有3-5份重的分裂精神分裂素，2-4重量份的戈麦西斯A和0.5-1.5重量份的前叶葡萄糖素H的复合木质素。五味子素是五味子素A，五味子甙B， 五味子三素或其混合物。 复杂的木质素还含有五味子三醇，阴离子基葡萄糖苷O，阴离子基葡聚糖P，表不列生，前假丝酵母或脱氧星星木脂素。 用于治疗2型糖尿病的保健食品含有复合木素素作为活性成分。 减少血糖的方法包括通过口服或静脉内注射，鼻内吸入或肌肉内或腹膜内给药将复合木酚素施用于受试者的步骤。
-
公开(公告)号：KR1020120061019A
公开(公告)日：2012-06-12
申请号：KR1020100109063
申请日：2010-11-04
Applicant: 한국식품연구원
IPC: A61K31/198 , A61P3/04 , A61P3/06 , A61P3/10
Abstract: PURPOSE: A pharmaceutical composition and health functional food containing selenomethionine are provided to prevent and treat obesity and lipid-related metabolic diseases. CONSTITUTION: A pharmaceutical composition for preventing and treating obesity and lipid-related metabolic diseases contains selenomethionine as an active ingredient. The pharmaceutical composition is manufactured in the form of powder, granules, tablets, capsules, suspension, emulsion, syrup, suppository, or sterilized injection solution. Selenomethionine suppresses differentiation of adipocyte. A health functional food contains selenomethionine as an active ingredient. The health functional food is used in the form of capsules, tablets, granules, powder, or beverage.
Abstract translation: 目的：提供含有硒代甲硫氨酸的药物组合物和保健功能食品，用于预防和治疗肥胖症和与脂质有关的代谢疾病。 构成：用于预防和治疗肥胖症和与脂质有关的代谢疾病的药物组合物含有硒代甲硫氨酸作为活性成分。 药物组合物以粉末，颗粒，片剂，胶囊，悬浮液，乳剂，糖浆，栓剂或灭菌注射液的形式制备。 硒代甲硫氨酸抑制脂肪细胞的分化。 健康功能食品含有硒代甲硫氨酸作为活性成分。 保健功能食品以胶囊，片剂，颗粒，粉末或饮料的形式使用。
-
公开(公告)号：KR1020120057690A
公开(公告)日：2012-06-07
申请号：KR1020100077227
申请日：2010-08-11
Applicant: 호서대학교 산학협력단 , 한국식품연구원
CPC classification number: A61K36/48 , A23L11/09 , A23V2200/328 , A61K2236/331 , Y10S514/866
Abstract: PURPOSE: A health functional food for anti-diabetes and diabetes treatment containing meju extract is provided to lower blood glucose in vivo and to treat and relieve type 2 diabetes without side effect. CONSTITUTION: An anti-diabetes agent contains meju extract as active ingredient. The extract includes water extract or C1-C4 low carbon number alcohol extract. A health function al food for treating acne contains the meju extract as an active ingredient. The extract is water.
Abstract translation: 目的：提供含有菊苣提取物的抗糖尿病和糖尿病治疗的保健功能食品，用于降低体内血糖，并治疗和缓解2型糖尿病，无副作用。 构成：抗糖尿病药含有菊苣提取物作为有效成分。 提取物包括水提取物或C1-C4低碳醇提取物。 用于治疗痤疮的健康功能食物含有作为活性成分的菊粉提取物。 提取物是水。
-
公开(公告)号：KR101145428B1
公开(公告)日：2012-05-17
申请号：KR1020090107975
申请日：2009-11-10
Applicant: 한국식품연구원
Abstract: 본 발명은 터키형 물김치 조성물 및 이의 제조 방법에 관한 것으로, 구체적으로 본 발명의 터키형 물김치 조성물은 순무, 콜라비 또는 이들의 혼합물을 포함하는 고형분; 및 소금, 설탕, 식초 및 물을 포함하는 액상 베이스를 포함하며, 본 발명의 물김치 제조 방법은 소금, 설탕 및 식초가 포함된 물을 가열하고 냉각하여 액상 베이스를 제조하는 액상 베이스 제조 단계; 및 상기 액상 베이스에 순무, 콜라비 또는 이들의 혼합물을 포함하는 고형분을 첨가하는 고형분 첨가 단계를 포함한다.
본 발명의 콜라비 물김치는 저염도, 약산성 및 저당도로 자극성이 약하고, 조직감이 우수하며, 다양한 색상으로 외관이 우수하여 터키인의 기호에 맞는다.
콜라비, 백년초, 터키, 물김치-
Patent Agency Ranking16.发明公开바이오케닌에이 또는 약리학적으로 허용되는 이의 염을 활성성분으로 함유하는 신생혈관생성과 관련된 질환의 치료용 조성물 无效用于治疗与包含生物素或其药学上接受的药物的血管生成相关的疾病的组合物
公开(公告)号：KR1020120029557A
公开(公告)日：2012-03-27
申请号：KR1020100091411
申请日：2010-09-17
Applicant: 한국식품연구원
IPC: A61K31/352 , A61K36/48 , A61P35/00 , A61P27/02
Abstract: PURPOSE: A composition containing biochanin A or pharmaceutically acceptable salt thereof for treating angiogenesis-associated diseases is provided to treat various diseases. CONSTITUTION: A composition for treating angiogenesis-associated diseases contains biochanin A or pharmaceutically acceptable salt thereof as an active ingredient. The angiogenesis-associated diseases are cancer, diabetetic retinopathy, rheumatic arthritis, psoriasis, inflammation, endometriosis, aging or hemandioma. A pharmaceutical composition for suppressing angiogenesis contains biochanin A or pharmaceutically acceptable salt thereof as an active ingredient.
Abstract translation: 目的：提供含有角鲨他汀A或其药学上可接受的盐用于治疗血管生成相关疾病的组合物以治疗各种疾病。 构成：用于治疗血管生成相关疾病的组合物含有作为活性成分的角鲨他汀A或其药学上可接受的盐。 血管生成相关疾病是癌症，糖尿病性视网膜病变，风湿性关节炎，牛皮癣，炎症，子宫内膜异位症，衰老或血管瘤。 用于抑制血管发生的药物组合物含有作为活性成分的角鲨他汀A或其药学上可接受的盐。
-
17.发明公开
公开(公告)号：KR1020120015221A
公开(公告)日：2012-02-21
申请号：KR1020100077551
申请日：2010-08-11
Applicant: 한국식품연구원
Abstract: PURPOSE: A composition containign sesamol or pharmaceutically acceptable salt is provided to suppress angiogenesis and to treat cancer, diabetic retinopathy, rheumatic arthritis, and psoriasis. CONSTITUTION: A composition for treating angiogenesis-associated diseases contains sesemol or pharmaceutically acceptable salt thereof as an active ingredient. The angiogenesis-associated diseases are cancer, diabetic retinopaghy, rheumatic arthritis, psoriasis, inflammation, endometriosis, and hemandioma. The sesamol or pharmaceutically acceptable salt thereof is contained in 0.1-10 wt%.
Abstract translation: 目的：提供含有塞萨莫酚或药学上可接受的盐的组合物以抑制血管生成并治疗癌症，糖尿病性视网膜病变，风湿性关节炎和牛皮癣。 构成：用于治疗血管生成相关疾病的组合物含有作为有效成分的西昔莫或其药学上可接受的盐。 血管生成相关疾病是癌症，糖尿病视网膜病，风湿性关节炎，牛皮癣，炎症，子宫内膜异位症和血管瘤。 芝麻酚或其药学上可接受的盐含量为0.1-10重量％。
-
公开(公告)号：KR1020120015206A
公开(公告)日：2012-02-21
申请号：KR1020100077529
申请日：2010-08-11
Applicant: 한국식품연구원
IPC: A61K31/785 , A61K31/765 , A61K31/74 , A61P3/04
CPC classification number: A61K31/785 , A23L33/175 , A61K31/195 , A61K31/765 , Y10S514/909
Abstract: PURPOSE: A composition containing poly gamma glutamic acid for preventing and treating obesity is provided to suppress differentiation of adipocytes and to activate AMPK(5'AMP-activated protein kinase). CONSTITUTION: A composition for preventing and treating obesity contains poly gamma glutamic acid(PGA) as an active ingredient. The molecular weight of PGA is 100kDa to 15,000kDa. The composition is a pharmaceutical composition or food additive. The composition further contains pharmacologically acceptable carrier. The composition is manufactured in the form of powder, granules, tablets, capsules, suspension, emulsion, syrup, external use, suppository, or sterilized injection solution.
Abstract translation: 目的：提供含有用于预防和治疗肥胖症的多聚谷氨酸的组合物，以抑制脂肪细胞的分化并激活AMPK（5'AMP激活的蛋白激酶）。 构成：用于预防和治疗肥胖症的组合物含有聚γ谷氨酸（PGA）作为活性成分。 PGA的分子量为100kDa至15,000kDa。 组合物是药物组合物或食品添加剂。 组合物还含有药理学上可接受的载体。 该组合物以粉末，颗粒，片剂，胶囊，悬浮液，乳剂，糖浆，外用，栓剂或灭菌注射液的形式制备。
-
公开(公告)号：KR1020110134647A
公开(公告)日：2011-12-15
申请号：KR1020100054336
申请日：2010-06-09
Applicant: 한국식품연구원
CPC classification number: A23L19/00 , A23L2/382 , A23L33/105 , A23V2200/32 , A23V2200/3262 , A23V2300/26
Abstract: PURPOSE: A food composition using dioscorea batatas, and a producing method thereof are provided to obtain sweet bean jelly, fermented rink, or gruel. CONSTITUTION: A producing method of a food composition using dioscorea batatas comprises the following steps: mixing purified water with one component selected from raw dioscorea batatas, dioscorea batatas powder, steamed dioscorea batatas, lactic acid bacteria fermented dioscorea batatas, or their mixture, and crushing the mixture for homogenizing; and injecting lactobacilus amylophilus and leuconostoc mesenteroides subsp. mesenteroides into the mixture, and adding additives including saccharide for fermenting for 20-50 hours at 25-40 deg C.
Abstract translation: 目的：提供使用薯A蓉的食品组合物及其制备方法，以获得甜豆冻，发酵溜冰场或稀饭。 构成：使用薯a蓉的食品组合物的制造方法，包括以下步骤：将纯净水与选自原料薯as，薯as粉，蒸食薯as，乳酸菌发酵薯as或其混合物中的一种成分混合， 混合均匀; 并注射乳酸杆菌和迷迭香肠粘膜亚种。 将肠内注射入混合物中，并加入包括糖类的添加剂，用于在25-40℃下发酵20-50小时。
-
20.发明公开
公开(公告)号：KR1020110125940A
公开(公告)日：2011-11-22
申请号：KR1020100045593
申请日：2010-05-14
IPC: A61K36/232 , A61K31/37 , A61P3/04 , A61P3/00
CPC classification number: A61K36/232 , A61K31/216 , A61K31/235 , A61K31/366 , Y10S514/909
Abstract: PURPOSE: A composition containing derivatives synthesized from decursin for preventing or treating obesity is provided to suppress fatty acid synthesis. CONSTITUTION: A composition for preventing or treating obesity contains decursinol benzoate which is synthedized from decursin. The decursinol benzoate suppresses fatty acid synthesis by AMPK(5' adenosine monophosphate-activated protein kinase) activity. A method for synthesizing decursinol benzoate comprises: a step of performing enfleurage of dried Angelicae gigantis Radix in methanol at room temperature for seven days and filtering; a step of suspending the methanol extract in distilled water and isolating dichloromethane; and a step of freeze-drying and performing silicagel column chromatography to prepare six fraction.
Abstract translation: 目的：提供含有由前代素合成的用于预防或治疗肥胖症的衍生物的组合物以抑制脂肪酸合成。 构成：用于预防或治疗肥胖症的组合物含有由前胡素合成的去甲基苯甲酸酯。 苯酚去甲酚抑制AMPK（5'腺苷单磷酸激活蛋白激酶）活性的脂肪酸合成。 合成前酚醇苯甲酸酯的方法包括：在室温下在甲醇中进行七天的过滤干燥的当归香草， 将甲醇提取物悬浮在蒸馏水中并分离二氯甲烷的步骤; 和冷冻干燥并进行硅胶柱色谱以制备6份。
-
-
-
-
-
-
-
-
-
Search Results
130
records
(took 0.028 seconds)
